)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Alimera Sciences
Alimera Sciences (ALIM) investor relations material
Alimera Sciences has been acquired by ANI Pharmaceuticals Inc
Alimera Sciences Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2024 earnings summary6 Aug, 2024
Executive summary
Net revenue for Q2 2024 rose 54% year-over-year to $27.0 million, driven by YUTIQ addition and international growth.
Gross profit increased 54% to $23.2 million, with gross margin steady at 86%.
Operating expenses rose to $23.2 million, mainly from merger-related costs, sales/marketing expansion, and YUTIQ amortization.
Net loss narrowed to $3.3 million from $10.0 million in Q2 2023.
Entered into a definitive merger agreement with ANI Pharmaceuticals, valuing equity at $320 million.
Financial highlights
Q2 2024 net revenue: $27.0M (+54% YoY); six months: $50.0M (+61% YoY).
Q2 2024 gross profit: $23.2M (+54% YoY); six months: $42.8M (+61% YoY).
Q2 2024 net loss: $3.3M (improved from $10.0M loss YoY); six months: $9.6M loss (improved from $15.0M loss YoY).
Adjusted EBITDA for Q2 2024: $6.7M (vs. $0.9M in Q2 2023).
Cash and equivalents at June 30, 2024: $10.9M.
Outlook and guidance
Management expects the ANI Pharmaceuticals acquisition to close later in 2024.
Current operations and financial assets expected to fund obligations for at least 12 months, including through the anticipated merger.
If the merger is not completed, alternative financing may be required; market conditions could impact availability and terms.
Forward-looking statements highlight growth opportunities and continued demand for products.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Alimera Sciences
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Alimera Sciences Inc. is a pharmaceutical company focused on the development and commercialization of prescription ophthalmic treatments. The company specializes in therapies for retinal diseases, aiming to improve vision and quality of life for patients. The company is headquartered in Alpharetta, Georgia, and its shares are listed on the NASDAQ.